Carlin is a vice president at Pathway Policy Group and a veterinarian. Paragas is the CEO and founder of DVLP Medicines and a virologist. The Food and Drug Administration’s recent decision to phase ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Parallel Bio, a biotech company pioneering human-first drug discovery, today announced it has raised $21 million Series A funding, led by AIX Ventures. The round ...

MOUNTAIN VIEW, CA, UNITED STATES, April 14, 2025 /EINPresswire.com/ -- Highlights: • Obatala Sciences and Ainnocence’s groundbreaking partnership addresses the ...

For decades, animal models have been the gold standard for preclinical testing of potential drugs. Yet, even the best animal models are not perfect. For example, small rodent species with engrafted ...

Despite swimming in different worlds, fish and humans are biologically much closer than one might think. Capitalizing on this ...

With support from EDB and A*Star, Japanese biopharma leader Chugai is using its research base in Singapore to create new therapies for global markets Read more at straitstimes.com. Read more at ...

A drug that makes human blood lethal to mosquitoes also acts as a potent contact insecticide absorbed through the feet, providing a promising new approach to combating insecticide resistance. A new ...

Scientists invented a pocket-sized model of the most common form of amyotrophic lateral sclerosis (ALS). The "disease-on-a-chip," made using stem cells, could pave the way for new treatments for the ...

Firefly collaborates with NVIDIA to enhance its BNA™ platform and aims to create a foundation model of the human brain. Firefly Neuroscience, Inc. has announced its acceptance into the NVIDIA Connect ...

Thiruvanathapuram: Kerala, the first state in the country to provide high-cost treatment free of charge for certain rare diseases for children, is set to expand coverage to all patients under the age ...